MassMutual Private Wealth & Trust FSB raised its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 60.4% in the fourth quarter, according to its most recent Form 13F filing with the ...

This was the stock's second consecutive day of losses.

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ...

Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets.

Citigroup has recently reduced BIO-TECHNE Corp (TECH) stock to Neutral rating, as announced on May 22, 2024, according to Finviz. Earlier, on February 8, 2024, Scotiabank had initiated the stock to ...

MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on another claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies ...

Bio-Techne Corporation TECH recently announced a co-marketing and co-promotion agreement with Waters Corporation. The latest partnership is aimed at expanding the reach of advanced biotherapeutic ...

Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi ...